Safe Orthopaedics (ALSAF) Stock Overview
A medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
ALSAF Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Safe Orthopaedics SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.64 |
| 52 Week High | €2.60 |
| 52 Week Low | €0.54 |
| Beta | -0.83 |
| 1 Month Change | 0% |
| 3 Month Change | 6.67% |
| 1 Year Change | -73.33% |
| 3 Year Change | -99.90% |
| 5 Year Change | -99.90% |
| Change since IPO | -99.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| ALSAF | FR Medical Equipment | FR Market | |
|---|---|---|---|
| 7D | 0% | -6.0% | -2.0% |
| 1Y | -73.3% | -43.0% | -0.02% |
Return vs Industry: ALSAF underperformed the French Medical Equipment industry which returned -41.7% over the past year.
Return vs Market: ALSAF underperformed the French Market which returned 2% over the past year.
Price Volatility
| ALSAF volatility | |
|---|---|
| ALSAF Average Weekly Movement | 5.2% |
| Medical Equipment Industry Average Movement | 4.2% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in FR Market | 9.5% |
| 10% least volatile stocks in FR Market | 2.2% |
Stable Share Price: ALSAF has not had significant price volatility in the past 3 months compared to the French market.
Volatility Over Time: ALSAF's weekly volatility has decreased from 20% to 5% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 87 | Nicolas Papillon | www.safeorthopaedics.com |
Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. The company was founded in 2010 and is headquartered in Fleurieux-sur-l'Arbresle, France.
Safe Orthopaedics SA Fundamentals Summary
| ALSAF fundamental statistics | |
|---|---|
| Market cap | €127.51k |
| Earnings (TTM) | -€4.67m |
| Revenue (TTM) | €5.36m |
Is ALSAF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALSAF income statement (TTM) | |
|---|---|
| Revenue | €5.36m |
| Cost of Revenue | €1.81m |
| Gross Profit | €3.55m |
| Other Expenses | €8.23m |
| Earnings | -€4.67m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -23.46 |
| Gross Margin | 66.24% |
| Net Profit Margin | -87.14% |
| Debt/Equity Ratio | -119.3% |
How did ALSAF perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/09 11:17 |
| End of Day Share Price | 2026/09/09 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Safe Orthopaedics SA is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Arnaud Riverain | GreenSome Finance |
| Pierre Vaurice | TPICAP Midcap |